iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding iSpecimen Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 7 | 9 | +2 |
| Shares | 1.12M | 916.3K | −205.0K (−18.3%) |
| Value | $8.10M | $5.35M | −$2.75M (−34.0%) |
New holders (7)
Institutions that held iSpecimen Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 27,677 | $162.0K | 0.00% |
| Telemus Capital, LLC | 24,400 | $142.0K | 0.01% |
| Citadel Advisors LLC | 12,755 | $74.0K | 0.00% |
| BlackRock Inc. | 6,007 | $35.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,365 | $8.00K | 0.00% |
| Total Clarity Wealth Management, Inc. | 942 | $5.00K | 0.00% |
| Wells Fargo & Company | 15 | $0 | 0.00% |
Sold out (5)
Institutions that held iSpecimen Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| NewGen Asset Management Ltd | 250,000 | $1.80M |
| Jane Street Group, LLC | 28,811 | $208.0K |
| Susquehanna International Group, LLP | 11,842 | $85.0K |
| Lindbrook Capital, LLC | 5,000 | $36.0K |
| UBS Group AG | 420 | $3.00K |